GDUFA Research Outcomes
Mixture APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are comprised of a mixtures (e.g., polymers) in generic products.
- 
                        Considerations in Developing Generic Peptide and Oligonucleotide Drug Products
                        Zhang, Deyi 
- 
                        Considerations in Demonstrating Complex API Sameness
                        Zhang, Deyi 
- 
                        Scientific Considerations in Submitting Synthetic Peptide Drug Products as ANDAs Referencing Peptide Drug products of rDNA origin
                        Zhang, Deyi 
- 
                        Demonstrating Complex API Sameness
                        Zhang, Deyi 
- 
                        Developing a Statistical Approach to Facilitate Sameness Assessment of Complex Heterogenous Active Pharmaceutical Ingredients
                        Weng, Yu Ting; Hu, Meng; Zhao, Liang; Wang, Chao; Shen, Meiyu; Gong, Xiajing 
- 
                        Identification and Quantitation of Host Cell Protein Impurities in Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry
                        Wang, Xiaoshi 
- 
                        Scientific Considerations for the Assessment Immunogenicity Risk of Generic Synthetic Peptide Products
                        Verthelyi, Daniela 
- 
                        In Vitro Binding Studies for Bioequivalence Demonstration
                        Sun, Wei-Jhe 
- 
                        Comparative Characterization of Highly Heterogeneous Drugs
                        Sasisekharan, Ram 
- 
                        Guidance for Peptide Products and Assessing Immunogenicity Risk
                        Pang, Eric